Concepedia

Kimberly Perkins

KP

2

Publications

22

Citations

2

H-Index

2022

Active since

Affiliations

Theravance Biopharma (United States)(Current)

Kimberly Perkins is an author at Theravance Biopharma (United States) specializing in medicine, pharmacology, and pre-clinical pharmacology.

Top concepts

AllergyMedicineImmunologyInflammationPharmacologyDrug DiscoveryPharmacotherapyGastroenterologyClinical PharmacologyMolecular Pharmacology

Publications per year

2022–2022

2

Publications

2

Gut-Selective Design of Orally Administered Izencitinib (TD-1473) Limits Systemic Exposure and Effects of Janus Kinase Inhibition in Nonclinical Species

Rhiannon N. Hardwick, Patrick Brassil, Ilaria Badagnani et al. · Toxicological Sciences · 2022 · 12 citations · Full text

Immunotoxicology, Gastrointestinal Pharmacology, Immunology +19

Lung-restricted ALK5 inhibition avoids systemic toxicities associated with TGFβ pathway inhibition

Jonathan Maher, Rui Zhang, Gopinath S. Palanisamy et al. · Toxicology and Applied Pharmacology · 2022 · 10 citations · Full text

Rows per page

1–2 of 2